FMIHX Performance — FMI Large Cap Fund, Investor Class
Data updated: 2026-08-14
FMIHX returned +3.16% year to date and +3.70% over one year to Jun 2026. Annualised returns are +9.91% over 3 years and +6.02% over 5 years. The fund trailed its US Mid-Cap Value category average: $100 invested three years ago grew to $133, against $148 for the category, and to $104 over one year, against $120. Volatility over the past three years was 13.54% a year. In the 12 months to Jun 2026 the fund lost a net $244.9M, and assets reached $1.07B.
FMIHX Growth of $100
What $100 invested in FMI Large Cap Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Mid-Cap Value category average over the same months.
| Period | FMIHX | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $104 | $120 |
| 3 years (Jul 2023 – Jun 2026) | $133 | $148 |
| 5 years (Jul 2021 – Jun 2026) | $134 | $154 |
| Since data start (Jul 2019 – Jun 2026) | $173 | $212 |
FMIHX Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +3.16% |
| 1 year | +3.70% |
| 3 years (annualised) | +9.91% |
| 5 years (annualised) | +6.02% |
FMIHX Annual Returns
Calendar-year total returns of FMI Large Cap Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +3.16% |
| 2025 | +6.18% |
| 2024 | +10.01% |
| 2023 | +21.06% |
| 2022 | −14.57% |
| 2021 | +18.64% |
| 2020 | +10.24% |
| 2019 (Jul–Dec) | +6.06% |
FMIHX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +2.5% | +1.3% | −8.7% | +4.7% | −1.0% | +5.0% | — | — | — | — | — | — |
| 2025 | +4.0% | −0.2% | −2.5% | −1.7% | +3.2% | +2.9% | −0.5% | +3.0% | −1.7% | −0.6% | +0.3% | 0.0% |
| 2024 | −0.8% | +3.9% | +5.3% | −2.8% | +2.9% | −0.4% | +3.2% | +1.7% | +1.4% | −3.3% | +6.7% | −7.2% |
| 2023 | +6.9% | −1.3% | −1.5% | +2.2% | −2.3% | +5.9% | +4.9% | −2.5% | −4.8% | −2.8% | +9.4% | +6.4% |
| 2022 | −3.8% | −3.0% | +0.6% | −6.7% | +2.8% | −9.4% | +6.0% | −5.2% | −6.9% | +7.8% | +7.8% | −3.6% |
| 2021 | −3.1% | +3.4% | +5.9% | +4.6% | +0.9% | −1.4% | +0.2% | +1.7% | −4.4% | +5.7% | −2.6% | +7.2% |
| 2020 | −3.2% | −7.4% | −14.6% | +9.4% | +5.2% | +0.2% | +5.5% | +3.7% | −1.6% | −1.0% | +13.3% | +3.3% |
| 2019 | — | — | — | — | — | — | +0.5% | −2.0% | +1.8% | +0.8% | +2.6% | +2.3% |
FMIHX Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 13.54%
- 3-year Sharpe ratio: 0.40 (vs 4.5% risk-free rate)
- Best month: +9.43% (Nov 2023)
- Worst month: −8.74% (Mar 2026)
FMIHX Fund Flows
Monthly money in and out of FMI Large Cap Fund, from SEC Form N-PORT.
- 12-month net flow: −$244.9M
- 12-month gross sales (incl. reinvestments): $237.2M
- Sales ÷ redemptions: 0.49×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $2.5M | $67.0M | −$64.5M |
| May 2026 | $2.5M | $44.4M | −$42.0M |
| Apr 2026 | $1.8M | $31.0M | −$29.2M |
| Mar 2026 | $7.9M | $18.2M | −$10.3M |
| Feb 2026 | $5.7M | $32.9M | −$27.2M |
| Jan 2026 | $4.5M | $42.9M | −$38.4M |
| Dec 2025 | $181.7M | $72.9M | $108.7M |
| Nov 2025 | $7.7M | $37.6M | −$29.9M |
| Oct 2025 | $2.6M | $46.5M | −$43.9M |
| Sep 2025 | $7.3M | $23.2M | −$15.9M |
| Aug 2025 | $9.4M | $26.5M | −$17.1M |
| Jul 2025 | $3.5M | $38.9M | −$35.4M |
FMIHX Assets Under Management
Net assets of FMI Large Cap Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $1.07B |
| 2026-03-31 | $1.11B |
| 2025-12-31 | $1.25B |
| 2025-09-30 | $1.39B |
| 2025-06-30 | $1.45B |
| 2025-03-31 | $1.44B |
| 2024-12-31 | $1.50B |
| 2024-09-30 | $1.67B |
| 2024-06-30 | $1.66B |
| 2024-03-31 | $1.71B |
| 2023-12-31 | $1.66B |
| 2023-09-30 | $1.62B |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.